Gooderham MJ, Kircik LH, Zirwas M, Lee M, Kempers SE, Draelos ZD, Ferris L, Jones TM, Saint-Cyr Proulx E, Bissonnette R, Bhatia N, Guenthner ST, Koppel RA, Welgus H, Merritt C, Elias M, Navale L, Higham RC, Droege M, Berk DR. The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study. J of Skin [Internet]. 2020 Oct. 27 [cited 2024 Jul. 3];4(6):s93. Available from: https://jofskin.org/33014/index.php/skin/article/view/1063